What is the current Price Target for the Ascletis Pharma Inc stock?

The average Ascletis Pharma Inc target price is HK$22.88. This is 203.23% higher than the current stock price. The highest price target is 331.41%, the lowest is 85.53%. 4 Analysts have issued a price target Ascletis Pharma Inc 2027 .

How high will the Ascletis Pharma Inc stock rise?

No reliable answer can be given as to how high the Ascletis Pharma Inc stock will rise. The performance of stocks, including the Ascletis Pharma Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Ascletis Pharma Inc stock today?

The performance of Ascletis Pharma Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Ascletis Pharma Inc stock fall?

The decline in Ascletis Pharma Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Ascletis Pharma Inc Forecast, price target & analysts

HK$6.96

7.75%

Hong Kong, Oct 09, 04:08 pm HKT. Closed.

ISIN

KYG0520K1094

Symbol

1672

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership Strategies

Ascletis Pharma Inc Target price 2026 - Analyst rating & recommendation

Ascletis Pharma Inc Classifications & Recommendation

Buy

78%

Hold

22%

Ascletis Pharma Inc Price Target

Target Price	HK$22.88
Price	HK$7.55
Potential	203.23% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Ascletis Pharma Inc 2027 . The average Ascletis Pharma Inc target price is HK$22.88. This is 203.23% register free of charge higher than the current stock price. The highest price target is HK$32.55 331.41% register free of charge , the lowest is HK$14.00 85.53% register free of charge .
	A rating was issued by 9 analysts: 7 Analysts recommend Ascletis Pharma Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Ascletis Pharma Inc stock has an average upside potential 2027 of 203.23% register free of charge . Most analysts recommend the Ascletis Pharma Inc stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Revenue Million HK$	2.37	19.26
	58.00%	712.81%
EBITDA Margin	-21,194.09%	-3,058.89%
	25.20%	85.57%

5 Analysts have issued a sales forecast Ascletis Pharma Inc 2026 . The average Ascletis Pharma Inc sales estimate is

unlock

. This is

unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics:

2025	HK$2.4m	58.00%
2026	HK$19.3m 712.81% unlock
2027	HK$87.7m 355.28% unlock
2028	HK$213m 142.53% unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share HK$	-0.43	-0.63
	22.86%	46.51%
P/E		negative
EV/Sales		345.76

6 Analysts have issued a Ascletis Pharma Inc forecast for earnings per share. The average Ascletis Pharma Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	HK$-0.43	22.86%
2026	HK$-0.63 46.51% unlock
2027	HK$-0.81 28.57% unlock
2028	HK$0.02 102.47% unlock

Current	-11.10	69.09%
2026	-12.03 8.42% unlock
2027	-9.36 22.19% unlock
2028	371.64 4,070.51% unlock

Based on analysts' sales estimates for 2026, the Ascletis Pharma Inc stock is valued at an EV/Sales of

unlock

and an P/S ratio of

unlock

This results in the following potential growth metrics and future valuations:

Current	6,000.51
2026	345.76 94.24% unlock
2027	75.94 78.04% unlock
2028	31.31 58.77% unlock

Current
2026	460.98 94.24% unlock
2027	101.25 78.04% unlock
2028	41.75 58.77% unlock

Ascletis Pharma Inc...

Discover more stocks with a high price target

NIO ADR 84.71%

Alibaba Group Holding Ltd 82.07%

Rheinmetall 74.56%

Tencent Holdings Ltd. 65.12%

Siemens Energy 46.74%

Uber Technologies 46.67%

ThyssenKrupp 42.99%

BMW 42.60%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now